GIPR Antibody Blocking peptide
GIPR Antibody Blocking peptide
Product Specifications
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of human GIPR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
F0025-75 100 Tests
FCRL4 (Fc Receptor-like Protein 4, FcR-like Protein 4, Fc Receptor Homolog 4, FcRH4, IFGP Family Protein 2, hIFGP2, Immune Receptor Translocation-associated Protein 1, FCRH4, IFGP2, IRTA1) (APC) discontinued
Sign In for Pricing
View Details 
MBS1377107-01 0.02 mg (E-Coli)
Recombinant Bacillus anthracis Putative regulator of ribonuclease activity (BA_3368, GBAA_3368, BAS3122)
Sign In for Pricing
View Details MBS1377107-02 0.1 mg (E-Coli)
Recombinant Bacillus anthracis Putative regulator of ribonuclease activity (BA_3368, GBAA_3368, BAS3122)
Sign In for Pricing
View Details MBS1377107-03 0.02 mg (Yeast)
Recombinant Bacillus anthracis Putative regulator of ribonuclease activity (BA_3368, GBAA_3368, BAS3122)
Sign In for Pricing
View Details